F8 and autoimmune hemolytic anemia: Acquired hemophilia A (AHA) is an ultra-rare bleeding disorder, about 1.48 incidence per million occurs per year, characterized by reduction of factor VIII (FVIII) activity due to the development of autoantibodies against FVIII [1–3].